RCM
ANGO icon

Rotella Capital Management’s AngioDynamics ANGO Stock Holding History

Rotella Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-35,919
Closed -$436K – 19
2015
Q4 		$436K Buy
+35,919
New +$442K 0.39% 80

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Rotella Capital Management's ANGO Position: Q1 2016 in Review

Rotella Capital Management sold out of AngioDynamics (ANGO) in Q1 2016, closing a stake of 35,919 shares — an estimated $436K sold.

Rotella Capital Management first reported a position in ANGO in Q4 2015 and held it in 1 quarter. The position peaked at $436K in Q4 2015. 121 funds tracked by Wall St. Rank hold ANGO as of Q1 2016.

  • Rotella Capital Management reported no remaining AngioDynamics position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 35,919 AngioDynamics shares in Q1 2016, an estimated $436K.
  • Rotella Capital Management first reported a position in AngioDynamics in Q4 2015 and held it in 1 quarter.
  • Rotella Capital Management's AngioDynamics position peaked at $436K in Q4 2015.
  • 121 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.